Literature DB >> 3340735

Life-shortening and disease incidence in C57Bl mice after single and fractionated gamma and high-energy neutron exposure.

J R Maisin1, A Wambersie, G B Gerber, G Mattelin, M Lambiet-Collier, B De Coster, J Gueulette.   

Abstract

C57Bl Cnb mice were exposed to single or fractionated d(50)+Be neutrons or 137Cs gamma-ray exposure at 12 weeks of age and were followed for life-shortening and disease incidence. The data were analyzed by the Kaplan-Meier procedure using as criteria cause of death and possible cause of death. Individual groups were compared by a modified Wilcoxon test according to Hoel and Walburg, and entire sets of different doses from one radiation schedule were evaluated by the procedure of Peto and by the Cox proportional hazard model. No significant difference was found in life-shortening of C57Bl mice between a single gamma and neutron exposure. Gamma fractionation was clearly less effective in reducing survival time than a single exposure. On the contrary, fractionation of neutrons was slightly although not significantly more effective in reducing life span than a single exposure. Life-shortening appeared to be a linear function of dose in all groups studied. The data on causes of death show that malignant tumors, particularly leukemias including thymic lymphoma, and noncancerous late degenerative changes in lung were the principal cause of life-shortening after a high single gamma exposure. Exposure delivered in 8 fractions 3 h apart was more effective in causing leukemias and all carcinomas and sarcomas than one delivered in 10 fractions 24 h apart or in a single session. Following a single neutron exposure, leukemias and all carcinomas and sarcomas appeared to increase somewhat more rapidly with dose than after gamma irradiation. No significant difference in the incidence of leukemias and all carcinomas and sarcomas was noted between a single and a fractionated neutron exposure.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3340735

Source DB:  PubMed          Journal:  Radiat Res        ISSN: 0033-7587            Impact factor:   2.841


  8 in total

1.  Irradiated stem cells and ageing of the haematopoietic system.

Authors:  Jiřina Vávrová; Zuzana Sinkorová; Martina Rezáčová; Aleš Tichý; Stanislav Filip; Jaroslav Mokrý; Emilie Lukášová
Journal:  Radiat Environ Biophys       Date:  2012-01-26       Impact factor: 1.925

Review 2.  Radiation carcinogenesis in experimental animals.

Authors:  J J Broerse; D W van Bekkum; C Zurcher
Journal:  Experientia       Date:  1989-01-15

3.  Acute myeloid leukemia induction in CBA/H mice by irradiation with fission neutrons as a function of exposure rate.

Authors:  R Huiskamp
Journal:  Radiat Environ Biophys       Date:  1991       Impact factor: 1.925

4.  Hormesis provides a generalized quantitative estimate of biological plasticity.

Authors:  Edward J Calabrese; Mark P Mattson
Journal:  J Cell Commun Signal       Date:  2011-02-25       Impact factor: 5.782

5.  Some biochemical aspects of the protective effect of strontium chloride on gamma-irradiated rats.

Authors:  F A Fahim; H M Roshdy; R M Yousri; M I Abady
Journal:  Biometals       Date:  1993       Impact factor: 2.949

6.  Immunomodulatory and cytoprotective role of RP-1 in gamma-irradiated mice.

Authors:  H C Goel; P K Agrawala; V Pathania; N Malhotra
Journal:  Mol Cell Biochem       Date:  2003-12       Impact factor: 3.396

7.  Fundamental flaws of hormesis for public health decisions.

Authors:  Kristina A Thayer; Ronald Melnick; Kathy Burns; Devra Davis; James Huff
Journal:  Environ Health Perspect       Date:  2005-10       Impact factor: 9.031

8.  Transition pattern and mechanism of B-lymphocyte precursors in regenerated mouse bone marrow after subtotal body irradiation.

Authors:  Deping Han; Mei Zhang; Jun Ma; Jingshen Hong; Chun Chen; Bingrong Zhang; Luqiang Huang; Wenlong Lv; Liangjie Yin; Amy Zhang; Hengshan Zhang; Zhenhuan Zhang; Sadasivan Vidyasagar; Paul Okunieff; Lurong Zhang
Journal:  PLoS One       Date:  2012-10-17       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.